Design of a prospective, multinational registry to evaluate patients hospitalized with hyponatremia: The HN Registry

Open Access Journal of Clinical Trials

Volumn 5, Issue 1, 2012, Pages 93-100

  Hauptman, Paul J ^a   Greenberg, Arthur ^b   Verbalis, Joseph G ^c   Amin, Alpesh ^d   Sigal, Samuel ^e   Chiong, Jun ^f   Chase, Sandra ^g   Dasta, Joseph ^h  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^f LOMA LINDA UNIVERSITY   (United States)

^g OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^h UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Design; Euvolemia; Hypervolemia; Methodology; Registry

Indexed keywords

ARTICLE; CLINICAL STUDY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE REGISTRY; EUROPE; HEART FAILURE; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; HYPONATREMIA; HYPOVOLEMIA; LENGTH OF STAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; STUDY DESIGN; YOUNG ADULT;

EID: 84889787230     PISSN: None     EISSN: 11791586     Source Type: Journal    
DOI: 10.2147/OAJCT.S49421     Document Type: Article

References (39)

1. Palmer BF, Gates JR, Lader M. Causes and management of hyponatremia. Ann Pharmacother. 2003;37(11):1694-1702.
2. Schrier RW, Bansal S. Diagnosis and management of hyponatremia in acute illness. Curr Opin Crit Care. 2008;14(6):627-634.
3. Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med. 2009;122(9):857-865.
4. Zilberberg MD, Exuzides A, Spalding J, etal. Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin. 2008;24(6):1601-1608.
5. Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med. 2010;170(3):294-302.
6. Gheorghiade M, Rossi JS, Cotts W, etal. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med. 2007;167(18):1998-2005.
7. Shorr AF, Tabak YP, Johannes RS, Gupta V, Saltzberg MT, Costanzo MR. Burden of sodium abnormalities in patients hospitalized for heart failure. Congest Heart Fail. 2011;17(1):1-7.
8. Doshi SM, Shah P, Lei X, Lahoti A, Salahudeen AK. Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. Am J Kidney Dis. 2012;59(2):222-228.
9. Zilberberg MD, Exuzides A, Spalding J, etal. Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study. BMC Pulm Med. 2008;8:16.
10. Huda MS, Boyd A, Skagen K, etal. Investigation and management of severe hyponatraemia in a hospital setting. Postgrad Med J. 2006;82(965):216-219.
11. Whyte M, Down C, Miell J, Crook M. Lack of laboratory assessment of severe hyponatraemia is associated with detrimental clinical outcomes in hospitalised patients. Int J Clin Pract. 2009;63(10): 1451-1455.
12. Hoorn EJ, Lindemans J, Zietse R. Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant. 2006;21(1):70-76.
13. Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta. 2003;337(1-2):169-172.
14. Upadhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia. Am J Med. 2006;119(7 Suppl 1):S30-S35.
15. Hirshberg B, Ben-Yehuda A. The syndrome of inappropriate antidiuretic hormone secretion in the elderly. Am J Med. 1997;103(4): 270-273.
16. Callahan MA, Do HT, Caplan DW, Yoon-Flannery K. Economic impact of hyponatremia in hospitalized patients: a retrospective cohort study. Postgrad Med. 2009;121(2):186-191.
17. Gill G, Huda B, Boyd A, etal. Characteristics and mortality of severe hyponatraemia-a hospital-based study. Clin Endocrinol (Oxf). 2006;65(2):246-249.
18. Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol. 1994;4(8):1522-1530.
19. Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. 2007;120(11 Suppl 1):S1-S21.
20. Androgué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000; 342(21):1581-1589.
21. Furst H, Hallows KR, Post J, etal. The urine/plasma electrolyte ratio: a predictive guide to water restriction. Am J Med Sci. 2000;319(4): 240-244.
22. Berl T. Impact of solute intake on urine flow and water excretion. J Am Soc Nephrol. 2008;19(6):1076-1078.
23. Sherlock M, Thompson CJ. The syndrome of inappropriate antidiuretic hormone: current and future management options. Eur J Endocrinol. 2010;162 Suppl 1:S13-S18.
24. Miller PD, Linas SL, Schrier RW. Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients. JAMA. 1980;243(24):2513-2515.
25. Oster JR, Epstein M, Ulano HB. Deterioration of renal function with demeclocycline administration. Curr Ther Res Clin Exp. 1976;20(6): 794-801.
26. Carrilho F, Bosch J, Arroyo V, Mas A, Viver J, Rodes J. Renal failure associated with demeclocycline in cirrhosis. Ann Intern Med. 1977;87(2):195-197.
27. Curtis NJ, van Heyningen C, Turner JJ. Irreversible nephrotoxicity from demeclocycline in the treatment of hyponatremia. Age Ageing. 2002;31(2):151-152.
28. Zegers de Beyl D, Naeije R, de Troyer A. Demeclocycline treatment of water retention in congestive heart failure. Br Med J. 1978; 1(6115):760.
29. Decaux G, Brimioulle S, Genette F, Mockel J. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. Am J Med. 1980;69(1):99-106.
30. Goldsmith SR. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure. Am J Cardiol. 2005;95(9A):14B-23B.
31. Dickstein K, Cohen-Solal A, Filippatos G, etal; ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10(10):933-989.
32. Kazory A. Haemodialysis, not ultrafiltration, can correct hyponatr-aemia in heart failure. Eur J Heart Fail. 2010;12(2):208.
33. VAPRISOL® (conivaptan hydrochloride) injection, for intravenous use [prescribing information]. Northbrook, IL: Astellas Pharma US, Inc; 2012.
34. SAMSCA™ (tolvaptan) tablets [prescribing information]. Rockville, MD: Otsuka America Pharmaceutical, Inc; 2013.
35. The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston: Little, Brown & Co; 1994:253-256.
36. Child CG, Turcotte JG. Surgery and portal hypertension. In: CG Child, editor. The liver and portal hypertension. Philadelphia: Saunders; 1964:50-64.
37. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31: 864-71.
38. Nallamothu BK, Hayward RA, Bates ER. Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation. 2008;118(12):1294-1303.
39. Dasta JF, Amin A, Chiong JR, Greenberg A, Verbalis JG, Chiodo J. Challenges in assessing the impact of hyponatremia management on length of stay: interim results from a global, multi-center, prospective, observational registry of hospitalized hypervolemic and euvolemic hyponatremic patients. Value Health. 2013;16(3):A18.